RHYTHMS – Eurostars Project

We are proud to announce that the RHYTHMS project was approved for funding/support by the Eurostars funding program.

In collaboration with our outstanding consortium partners – Scinus, MyCellHub and University Hospital Skåne – we will work towards the improvement of cell therapy manufacturing protocols. The RHYTHMS project aims to develop an advanced process control toolkit designed for advanced and real-time monitoring of the expansion of challenging cell types, such as induced pluripotent stem cells (iPSCs), that will allow:

• Data-driven process control
• Greater efficiency & reproducibility in iPSC culture
• A sustainable & scalable manufacturing protocol for high quality iPSCs

For Stemmatters this project represents an opportunity to further consolidate our capabilities in iPSC large-scale manufacturing as a CDMO focused on advanced regenerative medicine products. We are dedicated to driving cell therapy innovation, accelerating the development of life-changing therapies and ensuring they reach more patients worldwide.

Eurostars is part of the European Partnership on Innovative SMEs. This partnership is co-funded by the European Union through Horizon Europe.